Armer Thomas A

Chief Scientific Officer at MAP Pharmaceuticals, Inc.

Sold, on record
$4.5M
Dollars the filings state
Form 4 sales
8
Latest Jan 23, 2013
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    May 27, 2009 2009

    Sold 100,000 shares at $9.61 ($961k)

    Armer Thomas A, Chief Scientific Officer

    Sold 23.1% of holdings ($4.2M position)332,403 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Dec 14, 2009 +201 days

    Sold 10,000 shares at $9.54 ($95k)

    Armer Thomas A, Chief Scientific Officer

    Sold 2.9% of holdings ($3.3M position)332,403 shares leftFiling

  3. 3 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Mar 4, 2011 +445 days

    Sold 30,000 shares at $16.10 ($483k)

    Armer Thomas A, Chief Scientific Officer

    Sold 12.4% of holdings ($3.9M position)212,009 shares leftFiling

  4. 4 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Dec 19, 2011 +290 days

    Sold 20,000 shares at $14.00 ($280k)

    Armer Thomas A, Officer, Director

    Sold 8.1% of holdings ($3.5M position)227,855 shares leftFiling

  5. 5 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Feb 6, 2012 +49 days

    Sold 20,000 shares at $15.00 ($300k)

    Armer Thomas A, Chief Scientific Officer

    Sold 8.7% of holdings ($3.4M position)209,162 shares leftFiling

  6. 6 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Feb 8, 2012 +2 days

    Sold 26,201 shares at $16.00 ($419k)

    Armer Thomas A, Chief Scientific Officer

    Sold 12.5% of holdings ($3.3M position)182,961 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale MAP Pharmaceuticals, Inc.Plan not stated
    Feb 14, 2012 +6 days

    Sold 33,799 shares at $15.65 ($529k)

    Armer Thomas A, Chief Scientific Officer

    Sold 18.5% of holdings ($2.9M position)149,162 shares left1.5x usual sizeFiling

  8. 8 Form 4 sale MAP Pharmaceuticals, Inc.Unusual
    Jan 23, 2013 +344 days

    Sold 59,620 shares at $24.76 ($1.5M)

    Armer Thomas A, Chief Scientific Officer

    Sold 31.6% of holdings ($4.7M position)129,162 shares left2.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Armer Thomas A
Source
Jan 23, 2013Jan 25, 2013MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale59,620$1.5M31.6%UnusualSEC
Feb 14, 2012Feb 14, 2012MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale33,799$529k18.5%Plan not statedSEC
Feb 8, 2012Feb 10, 2012MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale26,201$419k12.5%Plan not statedSEC
Feb 6, 2012Feb 7, 2012MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale20,000$300k8.7%Plan not statedSEC
Dec 19, 2011Dec 21, 2011MAP Pharmaceuticals, Inc.Officer, DirectorForm 4 sale20,000$280k8.1%Plan not statedSEC
Mar 4, 2011Mar 8, 2011MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale30,000$483k12.4%Plan not statedSEC
Dec 14, 2009Dec 16, 2009MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale10,000$95k2.9%Plan not statedSEC
May 27, 2009May 28, 2009MAP Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale100,000$961k23.1%Plan not statedSEC